BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8258559)

  • 1. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma.
    Springfield D
    J Bone Joint Surg Am; 1993 Dec; 75(12):1880-1. PubMed ID: 8258559
    [No Abstract]   [Full Text] [Related]  

  • 2. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
    Menendez LR; Fideler BM; Mirra J
    J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
    Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
    Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
    Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
    Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.
    Kostakoglu L; Panicek DM; Divgi CR; Botet J; Healy J; Larson SM; Abdel-Dayem HM
    Eur J Nucl Med; 1996 Nov; 23(11):1558. PubMed ID: 9044869
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
    Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
    Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioisotopic exploration of sarcomas of the bone and soft tissue].
    Gongora R
    Bull Cancer; 1988; 75(5):459-67. PubMed ID: 3165035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of bone and soft tissue sarcomas].
    Furuse K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
    J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Singapore Cancer Network (SCAN) Guidelines for the Initial Evaluation, Diagnosis, and Management of Extremity Soft Tissue Sarcoma and Osteosarcoma.
    Singapore Cancer Network (SCAN) Sarcoma Workgroup
    Ann Acad Med Singap; 2015 Oct; 44(10):474-83. PubMed ID: 26763065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography and the orthopaedic surgeon.
    Smith MA; O'Doherty MJ
    J Bone Joint Surg Br; 2000 Apr; 82(3):324-5. PubMed ID: 10813162
    [No Abstract]   [Full Text] [Related]  

  • 12. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
    Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
    Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.
    Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
    Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium scans in Paget's sarcoma.
    Yeh SD; Rosen G; Benua RS
    Clin Nucl Med; 1982 Dec; 7(12):546-52. PubMed ID: 6959752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
    Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
    Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI and bone scan in osteosarcoma. Is preoperative assessment of tumor necrosis possible?
    Manfrini M; Spina V; Tarozzi C; Capanna R; Cerofolini E; Ruggieri P; Romagnoli R; Abbati A; Campanacci M
    Chir Organi Mov; 1990; 75(1 Suppl):38-40. PubMed ID: 2249553
    [No Abstract]   [Full Text] [Related]  

  • 17. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
    Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
    J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical theory, staging, definition and treatment of musculoskeletal sarcomas.
    Kerns LL; Simon MA
    Surg Clin North Am; 1983 Jun; 63(3):671-96. PubMed ID: 6867918
    [No Abstract]   [Full Text] [Related]  

  • 19. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis.
    Knop J; Delling G; Heise U; Winkler K
    Chir Organi Mov; 1990; 75(1 Suppl):36-7. PubMed ID: 2249552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications for lymphography in bone and soft tissue tumors].
    Blaudow K; Schmidt F; Drescher KH; Fleissner R; Kerner U
    Radiol Diagn (Berl); 1983; 24(3):305-7. PubMed ID: 6577517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.